NCT00246376View on ClinicalTrials.gov

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

NACompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

February 29, 2012

Conditions
Cardiovascular DiseasesHeart DiseasesHIV InfectionsHyperlipidemiaHypertriglyceridemiaInsulin ResistanceAtherosclerosis
Interventions
BEHAVIORAL

Diet

ATP-III diet

BEHAVIORAL

Exercise

Supervised exercise in study gym

DRUG

Niacin

Niaspan, titrated up to 2 grams per day

DRUG

Fenofibrate

Tricor, 120 mg per day

OTHER

Placebos

Placebos for Niaspan and Tricor

Trial Locations (1)

77098

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Legacy Community Health Center

UNKNOWN

lead

Baylor College of Medicine

OTHER

NCT00246376 - Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia | Biotech Hunter | Biotech Hunter